idarubicin has been researched along with Leukocytopenia in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (82.35) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 1 (5.88) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberto, P; Cavalli, F; Joss, RA; Obrecht, JP; Siegenthaler, P; VanHelvoirt, A | 1 |
Bachmann, E; Beilstein, AK; Zbinden, G | 1 |
Bonadonna, G; Bonfante, V; Ferrari, L; Villani, F | 1 |
Carde, P; Chahine, G; Hayat, M; Hurteloup, P; Kamioner, D; Parmentier, C; Pico, JO; Schlumberger, M | 1 |
Cotter, SM; L'Heureux, DA; Moore, AS; Rand, WM; Ruslander, D | 1 |
de Valeriola, DL; Lasota, WS; Piccart, MJ | 1 |
Fukushima, T; Goto, N; Kuraishi, Y; Ogawa, M; Ohno, R; Okabe, KI; Ueda, T; Urabe, A; Yamashita, T | 1 |
Bastholt, L; Dalmark, M; Gadeberg, CC; Jakobsen, A; Mouridsen, HT; Sandberg, E | 1 |
Capnist, G; Chisesi, T; de Dominicis, E; Dini, E | 1 |
Bell, D; Dalley, D; Levi, J; Presgrave, P; Woods, R | 1 |
Beer, M; Crespeigne, N; Dodion, P; Finet, C; Kenis, Y; Nicaise, C; Rozencweig, M | 1 |
Di Lauro, L; Di Pietro, N; Ganzina, F; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
Bodey, GP; Burgess, M; Feun, LG; Kavanagh, J; Loo, TL; Lu, K; Savaraj, N | 1 |
Hakes, TB; Raymond, V | 1 |
Meyer, D; Nagel, GA; Schuff-Werner, P; Wander, HE | 1 |
Burke, MT; Casper, ES; Cibas, IR; Fiore, JJ; Gralla, RJ; Heelan, RT; Kelsen, DP; Kris, MG | 1 |
Martoni, A; Pacciarini, MA; Pannuti, F | 1 |
1 review(s) available for idarubicin and Leukocytopenia
Article | Year |
---|---|
Potential role of oral anthracyclines in older patients with cancer.
Topics: Administration, Oral; Aged; Biological Availability; Clinical Trials as Topic; Half-Life; Humans; Idarubicin; Intestinal Absorption; Leukopenia; Menogaril; Metabolic Clearance Rate; Neoplasms | 1994 |
2 trial(s) available for idarubicin and Leukocytopenia
Article | Year |
---|---|
A pharmacokinetic study of idarubicin in Japanese patients with malignant lymphoma: relationship with leukocytopenia and neutropenia.
Topics: Aged; Antibiotics, Antineoplastic; Area Under Curve; Biotransformation; Daunorubicin; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Idarubicin; Japan; Leukocyte Count; Leukopenia; Lymphoma; Male; Middle Aged; Neutropenia | 2001 |
The new anthracycline 4-demethoxydaunorubicin by oral route in advanced pretreated breast cancer and melanoma. A pilot study.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Clinical Trials as Topic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Vomiting | 1985 |
14 other study(ies) available for idarubicin and Leukocytopenia
Article | Year |
---|---|
Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Daunorubicin; Digestive System; Drug Evaluation; Heart; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Middle Aged | 1984 |
Toxicological studies with a novel synthetic anthracycline, the bis-hydrazone bridged analog of 4-demethoxydaunorubicin (SC-33428).
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Body Weight; Daunorubicin; Doxorubicin; Electrocardiography; Female; Idarubicin; Leukopenia; Rats; Rats, Inbred Strains; Time Factors | 1984 |
Phase I study of 4-demethoxydaunorubicin.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Child, Preschool; Daunorubicin; Digestive System; Drug Evaluation; Female; Humans; Idarubicin; Injections, Intravenous; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1983 |
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Gastrointestinal Diseases; Humans; Idarubicin; Leukemia; Leukopenia; Male; Middle Aged | 1984 |
Efficacy of, and toxicoses associated with, oral idarubicin administration in cats with neoplasia.
Topics: Administration, Oral; Animals; Anorexia; Cat Diseases; Cats; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Idarubicin; Leukopenia; Lymphoma; Male; Neoplasms; Vomiting | 1995 |
Oral idarubicin in the treatment of advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Middle Aged | 1989 |
A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged; Multiple Myeloma; Nausea; Thrombocytopenia | 1988 |
A phase II trial of oral 4'demethoxydaunorubicin in advanced colorectal carcinoma.
Topics: Administration, Oral; Aged; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged | 1988 |
Phase I study of oral idarubicin given with a weekly schedule.
Topics: Administration, Oral; Adult; Aged; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged; Neoplasms; Risk; Thrombocytopenia | 1986 |
Phase II trial with oral idarubicin in advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Middle Aged; Thrombocytopenia | 1986 |
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR).
Topics: Daunorubicin; Drug Evaluation; Humans; Idarubicin; Leukopenia; Liver Diseases; Metabolic Clearance Rate | 1986 |
Phase II study of idarubicin in advanced endometrial carcinoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Middle Aged; Uterine Neoplasms | 1987 |
Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Neoplasm Metastasis | 1986 |
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Lung Neoplasms; Male; Middle Aged | 1985 |